Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
27826
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Study part: Informed consent (Screening) Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (4)
- 11/25/17 11/25/17 -
- 11/25/17 11/25/17 -
- 11/30/17 11/30/17 -
- 12/31/17 12/31/17 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
November 30, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Screening Informed consent GOAL Trial B-cell Lymphoma NCT02499003
Screening Informed consent GOAL Trial B-cell Lymphoma NCT02499003
Similar models
Screening Informed consent GOAL Trial B-cell Lymphoma NCT02499003
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Subject ID
Item
Subject ID
text
Site Number
Item
Site No
text
Screening number
Item
Screening no
text
Informed consent availability
Item
Signed and dated informed consent of the patient is available before start of any trial specific procedures
boolean
Date of informed consent
Item
Date of informed consent
date
Participation in contributing scientific investigations
Item
Participation in contributing scientific investigations
boolean